Related Experiment Video
Updated: Mar 26, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular
1Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, USA.
Abstract:
To achieve cellular transformation, most oncogenic retroviruses use transduction by proto-oncogene capture or insertional mutagenesis, whereby provirus integration disrupts expression of tumor suppressors or proto-oncogenes. In contrast, the Human T-cell leukemia virus type 1 (HTLV-I) has been classified in a separate class referred to as "transactivating retroviruses". Current views suggest that the viral encoded Tax protein transactivates expression of cellular genes leading to deregulated growth and transformation. However, if Tax-mediated transactivation was indeed sufficient for cellular transformation, a fairly high frequency of infected cells would eventually become transformed. In contrast, the frequency of transformation by HTLV-I is very low, likely less than 5%. This review will discuss the current understanding and recent discoveries highlighting critical functions of Tax in cellular transformation. HTLV-I Tax carries out essential functions in order to override cell cycle checkpoints and deregulate cellular division. In addition, Tax expression is associated with increased DNA damage and genome instability. Since Tax can inhibit multiple DNA repair pathways and stimulate unfaithful DNA repair or bypass checkpoints, these processes allow accumulation of genetic mutations in the host genome. Given this, a "Random Mutagenesis" transformation model seems more suitable to characterize the oncogenic activities of HTLV-I.
Insights
Human T-cell leukemia virus type 1 (HTLV-I) uses its Tax protein to disrupt cell cycle checkpoints and DNA repair, leading to genetic mutations and cancer. This "Random Mutagenesis" model better explains HTLV-I
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Most oncogenic retroviruses cause cellular transformation via proto-oncogene capture or insertional mutagenesis.
- Human T-cell leukemia virus type 1 (HTLV-I) is a transactivating retrovirus, with its Tax protein thought to drive transformation.
- However, the low transformation frequency (<5%) challenges the sufficiency of Tax-mediated transactivation alone.
Purpose of the Study:
- To review current understanding and recent discoveries on the critical functions of Tax in HTLV-I-mediated cellular transformation.
- To highlight Tax's role in overriding cell cycle checkpoints and deregulating cellular division.
- To explore Tax's impact on DNA damage, genome instability, and repair pathways.
Main Methods:
- Review of existing literature on HTLV-I, Tax protein functions, and cellular transformation mechanisms.
- Analysis of experimental evidence regarding Tax's effects on cell cycle regulation and DNA repair.
- Comparison of different models of viral oncogenesis.
Main Results:
- HTLV-I Tax overrides cell cycle checkpoints and deregulates cell division.
- Tax expression increases DNA damage and genome instability.
- Tax inhibits DNA repair pathways and promotes error-prone repair or checkpoint bypass, facilitating mutation accumulation.
Conclusions:
- Tax-mediated transactivation alone is insufficient for HTLV-I's low transformation frequency.
- Tax's ability to induce DNA damage, inhibit repair, and deregulate cell division supports a 'Random Mutagenesis' model for HTLV-I oncogenesis.
- This model better characterizes the oncogenic activities of HTLV-I.
More Related Videos
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
08:21Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry
Published on: September 1, 2019
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle